26
Views
16
CrossRef citations to date
0
Altmetric
Article

Clinical Efficacy of a Vaccine-Immunostimulant Combination in the Prevention of Influenza in Patients with Chronic Obstructive Pulmonary Disease and Chronic Asthma

Pages 273-278 | Published online: 18 Jul 2013

References

  • Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly person living in the community. N Engl J Med 1994; 331: 778–784.
  • Patriarca PA, Strikas RA. Influenza vaccine for healthy adults? (Editorial) N Engl J Med 1995; 333: 933–934.
  • Annuario Statistico Italiano 1990. Sistema Statistico Nazionale. Istituto Nazionale di Statistica.
  • Prevention and control of influenza: vaccines; recom-mendations of the Advisory Committee on Immunisation Practices (ACIP). MA/ 1\1(TR Morb Mort Wkly Rep 1995; 44: 1-22.
  • Comprehensive delivery of adult vaccination - Minnesota, 1986-1992. MMWR Morb Mortal Wkly Rep 1993: 42: 768–770.
  • Influenza vaccination coverage levels in selected sites - United States, 1989. MMWR Morb Mortal Wkyl Rep 1990; 39: 165-167.
  • Douglas RG. Prophylaxis and treatment of influenza. N Engl J Med 1990; 322: 442–450.
  • Kilbourne ED. Inactivated influenza vaccines. In: Ploktin SA, Montimer EA eds, Vaccines WB. Saunders, Philadelphia, 1988: 420-434.
  • Profeta ML. Ulteriori osservazioni sull'efficacia immu-nizzante di vaccini antiinfluenzali inattivati in periodo interepidemico. Igiene Modema 1979; 72: 91–106.
  • Profeta ML. Ricerce sull'efficacia immunizzante dei vaccini antiinfluenzali. Nuovi Annali di Igiene e Microbiologia 1982; 33: 785–797.
  • Jorden MC, Rousseau WE, Tegtmeier GE, Noble GR, Hugh RD, Chin T. Immunogenicity of inactivated influenza virus vaccine in chronic renal failure. Ann Intern Med 1973; 79: 790–794.
  • Pabico RC, Douglas RG, Betts RF, Mc Kenna BA, Freeman RR. Antibody response to influenza vaccination in renal transplant patients: correlation with allograft function. Ann Intern Med 1976; 85: 431–436.
  • Miotti PG, Nelson KE, Dalla Betta GA, Farzadegan H, Margolick J, Clement HL. The influence of HIV infection on antibody response to a two dose regimen of influenza vac-cines. JAMA 1989; 262: 779–783.
  • Gross PA, Quinnan GV, Weksler ME, Gaerlan PF, Denning CR. Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc 1988; 36: 209–212.
  • Hudgel DW, Langston L Jr, Seiner JC, McIntosh K. Viral and bacterial infections in adults chronic asthma. Am Rev Resp Dis 1979; 120: 393–397.
  • Anthonisen NR. Prognosis in chronic obstructive pul-monary disease. Am Rev Resp Dis 1986; 133: 14–20.
  • Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard F. Optimal assessment and management of chron-ic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398–1420.
  • Fietta A. Bersani C, De Rose V. Evaluation of systemic host defense mechanisms in chronic bronchitis. Respiration 1988; 53: 37–43.
  • Gialdroni Grassi G, De Rose V. Immunomodulanti prospettive di impiego in pneumologia. In Pneumologia, Grassi C. ed. UTET, Torino 1990: 955-981.
  • Pujiol JL, Klein B, Godard PH, Dussourd D'Hinterland L. Bacterial ribosomal immunostimulants prime alveolar macrophages in vivo to produce interleukin 1 in vitro. Chest 1991; 100: 644–648.
  • Berle MB. Bacterial lysates and ribosomed ad inducers of specific immune responses: a comparative study. Scand J Immunol 1993; 38 (5): 496–498.
  • Dowdle WA, Kendal AP, Noble GR. Influenza viruses. In: Lennette EM, Schmidt NJ, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. Am Publ Hlth Assoc Washington. 1979; 585-609.
  • Profeta ML, Ballerini P. La prova di inibizione della emoagglutinazione per i virus influenzali con antigeni trattati con tween-etere. Ann Sclavo 1981; 23: 530–542.
  • Stuart Harris GM, Shikd GC. In: Influenza. The virus-es and the disease. London: E. Arnold. 1976: 144.
  • Margolis KL, Poland GA, Nichol KL. Frequency of adverse reactions after influenza vaccination. Am J Med 1990; 88: 27.
  • Krebs A, Adamczyk B, Brachmann I. Tolerance and immunogenic effect of preventive influenza vaccination in patients with chronic lung diseases. Z Erkr Atmungsorgane 1986; 167: 109–115.
  • Ghirga G, Ghirga P, Rodin° P, Presti A. Safety of the subunit influenza vaccine in asthmatic children (letter). Vaccine 1991; 9: 913–914.
  • Albazzaz Mk, Harvey SE, Grilli EA, Gaul EO, Roome A. Subunit influenza vaccination in adults with asthma: effect on clinical state, airway reactivity, and antibody response. Br Med J 1987; 294: 1196–1197.
  • Kava T, Laitinen L. Effects of killed and live attenuated influenza vaccine on symptoms and specific airway conduc-tance in asthmatics and healthy subjects. Allergy 1985; 40: 42–47.
  • Banks J, Bevan C, Fennerty A, Ebden P, Walters EH, Smith A. Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients. Eur J Respir Dis 1985; 66: 268–272.
  • Sillan F. Modern vaccines. Pneumococcus and influen-za. Lancet 1990; 335: 898–907.
  • Profeta ML, Guidi G, Meroni PL, Palmieri R, Palladino G, Cantone V, Zanussi C. Influenza vaccination with adjuvant RU41740 in the elderly. Lancet. 1987; 1: 973.
  • Profeta ML, Pregliasco F, Fraizzoli G. Studio dell'effet-to adiuvante di un vaccino batterico polivalente sulla risposta anticorpale da vaccinazione antiinfluenzale. Igiene Modema 1990; 94: 1021–1029.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.